Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00672919 · ClinicalTrials.gov registry record · Phase 4

Pioglitazone Study of Triglyceride Changes in Subjects With Type 2 Diabetes After Conversion From Rosiglitazone.

A Phase 4 study of Diabetes Mellitus, sponsored by Takeda.

Completed
Registry status
Phase 4
Development phase
305
Enrollment target
20
Study locations

NCT00672919 is a Phase 4 study of Diabetes Mellitus that has completed, run by Takeda. The registered enrollment target is 305 participants, below the 1,866-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (84% lower). The trial reports 20 study locations across 8 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00672919, a Phase 4 study of Diabetes Mellitus, has completed, sponsored by Takeda.

COMPLETED
Registry status
Phase 4
Development phase
305 participants
Enrollment target
20
Study locations

Study Summary

The purpose of this study is to measure the triglyceride changes in subjects with type 2 diabetes mellitus taking pioglitazone, once daily (QD), following treatment conversion from rosiglitazone.

Conditions Studied

Diabetes Mellitus

Interventions

  • DRUG Pioglitazone

Study Locations (20)

Florida

  • - Aventura
  • - Hollywood
  • - Jacksonville
  • - Miami
  • - North Miami Beach
  • - Tallahassee
  • - West Palm Beach

California

  • - Bellflower
  • - Burlingame
  • - Fresno
  • - La Jolla
  • - Long Beach
  • - Pasadena

Connecticut

  • - Norwalk
  • - Waterbury

Alabama

  • - Birmingham

Arizona

  • - Tucson

Colorado

  • - Arvada

Georgia

  • - Columbus

Idaho

  • - Idaho Falls

Trial Details

FieldValue
Enrollment Target 305 participants
Start Date 2003-11
Est. Completion 2004-08
Phase Phase 4

Sponsor

Takeda

408 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00672919

The ClinicalTrials.gov registry entry for NCT00672919 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 305 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,866-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (84% lower). The listed sponsor is Takeda, which has 408 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Diabetes Mellitus appearing as the primary indexed condition, and to 1 intervention - of which Pioglitazone is the first listed.

NCT00672919 reports 20 study locations spanning 8 distinct geographic areas - top geographies include Florida, California, Connecticut.

Frequently Asked Questions

What is clinical trial NCT00672919 about?

NCT00672919 is a clinical study titled "Pioglitazone Study of Triglyceride Changes in Subjects With Type 2 Diabetes After Conversion From Rosiglitazone.". The purpose of this study is to measure the triglyceride changes in subjects with type 2 diabetes mellitus taking pioglitazone, once daily (QD), following treatment conversion from rosiglitazone.

What is the current status of trial NCT00672919?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 305 participants. The study started on 2003-11. Estimated completion is 2004-08.

What conditions does trial NCT00672919 study?

This clinical trial studies the following conditions: Diabetes Mellitus.

What interventions are being tested in trial NCT00672919?

The interventions under investigation include: Pioglitazone (DRUG).

Who is sponsoring clinical trial NCT00672919?

This trial is sponsored by Takeda, which has 408 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00672919 being conducted?

This trial has 20 study locations across Alabama, Arizona, California, Colorado, Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Diabetes Mellitus

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Diabetes Mellitus

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.